🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- M82618121 (prev. 88339A203 )
- Market Cap
- Micro Cap
- Previous Symbol
- SPRCY (changed 8/27/2021)
- Previous Name
- SciSparc Ltd. ADR
Business: SciSparc Ltd. is a specialty clinical-stage pharmaceutical company with a focus on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive cannabidiol (CBD): SCI-110 for the treatment of Tourette syndrome, for the treatment of Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and status epilepticus.
Notes: June 24, 2025 -- SciSparc Ltd., a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that it intends to effect a one-for-twenty one (1-for-21) reverse share split (the “Reverse Share Split”) of the Company’s issued and outstanding ordinary shares, no par value per share (the “Ordinary Shares”), effective at the market open on July 3, 2025. The new CUSIP number for the Ordinary Shares following the Reverse Share Split will be M82618121.
Company Contact
- CEO
- Oz Adler
- CFO
- Oz Adler
- Investor Relations
- IR@scisparc.com